Krystal Biotech Other Equity Adjustments (Quarterly) Analysis

Krystal Biotech, Inc. (KRYS)

267.65 -6.94 (-2.53%) USD | NASDAQ | Feb 24, 13:29

View Other Equity Adjustments (Quarterly) for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Equity Adjustments (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Equity Adjustments (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Equity Adjustments (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
DexCom, Inc.	Upgrade
Alkermes Plc	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade